Please use this identifier to cite or link to this item: https://doi.org/10.3390/ijms19051310
Title: Noncoding RNA: RNA regulatory networks in cancer
Authors: Chan, J.J 
Tay, Y 
Keywords: complementary RNA
cyclin E
cytohesin 1
high mobility group A2 protein
long untranslated RNA
messenger RNA
microRNA
phosphatidylinositol 3,4,5 trisphosphate 3 phosphatase
phosphatidylinositol 4,5 bisphosphate 3 kinase
pyruvate dehydrogenase kinase
RNA H19
Smad7 protein
somatomedin B
STAT3 protein
transcription factor ZEB1
transcriptome
tyrosinase related protein 1
untranslated RNA
zinc finger E box binding homeobox 2
long untranslated RNA
microRNA
RNA
RNA, circular
tumor marker
bioinformatics
breast cancer
cancer growth
colorectal carcinoma
DNA damage
epithelial mesenchymal transition
gallbladder cancer
gene control
gene expression
glioma
human
KRASP1 gene
liver cell carcinoma
malignant neoplasm
melanoma
mouth squamous cell carcinoma
NEAT1 gene
non small cell lung cancer
nonhuman
oncogene
pancreas cancer
phenotype
protein expression
pseudogene
regulatory RNA sequence
Review
signal transduction
stomach cancer
treatment outcome
tumor suppressor gene
TYRP1 gene
upregulation
carcinogenesis
gene expression profiling
gene expression regulation
genetics
metabolism
neoplasm
RNA transport
Biomarkers, Tumor
Carcinogenesis
Gene Expression
Gene Expression Profiling
Gene Expression Regulation, Neoplastic
Humans
MicroRNAs
Neoplasms
Pseudogenes
RNA
RNA Transport
RNA, Long Noncoding
Issue Date: 2018
Citation: Chan, J.J, Tay, Y (2018). Noncoding RNA: RNA regulatory networks in cancer. International Journal of Molecular Sciences 19 (5) : 1310. ScholarBank@NUS Repository. https://doi.org/10.3390/ijms19051310
Abstract: Noncoding RNAs (ncRNAs) constitute the majority of the human transcribed genome. This largest class of RNA transcripts plays diverse roles in a multitude of cellular processes, and has been implicated inmany pathological conditions, especially cancer. The different subclasses of ncRNAs include microRNAs, a class of short ncRNAs; and a variety of long ncRNAs (lncRNAs), such as lincRNAs, antisense RNAs, pseudogenes, and circular RNAs. Many studies have demonstrated the involvement of these ncRNAs in competitive regulatory interactions, known as competing endogenous RNA (ceRNA) networks, whereby lncRNAs can act as microRNA decoys to modulate gene expression. These interactions are often interconnected, thus aberrant expression of any network component could derail the complex regulatory circuitry, culminating in cancer development and progression. Recent integrative analyses have provided evidence that new computational platforms and experimental approaches can be harnessed together to distinguish key ceRNA interactions in specific cancers, which could facilitate the identification of robust biomarkers and therapeutic targets, and hence, more effective cancer therapies and better patient outcome and survival. © 2018 by the authors. Licensee MDPI, Basel, Switzerland.
Source Title: International Journal of Molecular Sciences
URI: https://scholarbank.nus.edu.sg/handle/10635/176205
ISSN: 1661-6596
DOI: 10.3390/ijms19051310
Appears in Collections:Elements
Staff Publications

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_3390_ijms19051310.pdf1.84 MBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.